185 related articles for article (PubMed ID: 20041594)
1. Obstructive sleep apnea and aldosterone.
Svatikova A; Olson LJ; Wolk R; Phillips BG; Adachi T; Schwartz GL; Somers VK
Sleep; 2009 Dec; 32(12):1589-92. PubMed ID: 20041594
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine and Inflammatory Responses to Losartan and Continuous Positive Airway Pressure in Patients with Hypertension and Obstructive Sleep Apnea. A Randomized Controlled Trial.
Thunström E; Manhem K; Yucel-Lindberg T; Rosengren A; Lindberg C; Peker Y
Ann Am Thorac Soc; 2016 Nov; 13(11):2002-2011. PubMed ID: 27548072
[TBL] [Abstract][Full Text] [Related]
3. The impact of obstructive sleep apnea syndrome on renin and aldosterone.
Lykouras D; Theodoropoulos K; Sampsonas F; Lagiou O; Lykouras M; Spiropoulou A; Flordellis C; Alexandrides T; Karkoulias K; Spiropoulos K
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4164-70. PubMed ID: 26592843
[TBL] [Abstract][Full Text] [Related]
4. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.
Pratt-Ubunama MN; Nishizaka MK; Boedefeld RL; Cofield SS; Harding SM; Calhoun DA
Chest; 2007 Feb; 131(2):453-9. PubMed ID: 17296647
[TBL] [Abstract][Full Text] [Related]
5. Does continuous positive airway pressure reduce aldosterone levels in patients with obstructive sleep apnea?
Yang SJ; Jiang XT; Zhang XB; Yin XW; Deng WX
Sleep Breath; 2016 Sep; 20(3):921-8. PubMed ID: 26779900
[TBL] [Abstract][Full Text] [Related]
6. Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone.
Follenius M; Krieger J; Krauth MO; Sforza F; Brandenberger G
Sleep; 1991 Jun; 14(3):211-7. PubMed ID: 1896722
[TBL] [Abstract][Full Text] [Related]
7. Precision Medicine in Patients With Resistant Hypertension and Obstructive Sleep Apnea: Blood Pressure Response to Continuous Positive Airway Pressure Treatment.
Sánchez-de-la-Torre M; Khalyfa A; Sánchez-de-la-Torre A; Martinez-Alonso M; Martinez-García MÁ; Barceló A; Lloberes P; Campos-Rodriguez F; Capote F; Diaz-de-Atauri MJ; Somoza M; González M; Masa JF; Gozal D; Barbé F;
J Am Coll Cardiol; 2015 Sep; 66(9):1023-32. PubMed ID: 26314530
[TBL] [Abstract][Full Text] [Related]
8. Diurnal and nocturnal serum melatonin concentrations after treatment with continuous positive airway pressure in patients with obstructive sleep apnea.
Barnaś M; Maskey-Warzęchowska M; Bielicki P; Kumor M; Chazan R
Pol Arch Intern Med; 2017 Sep; 127(9):589-596. PubMed ID: 28724876
[TBL] [Abstract][Full Text] [Related]
9. CPAP Therapy Delays Cardiovagal Reactivation and Decreases Arterial Renin-Angiotensin System Activity in Humans With Obstructive Sleep Apnea.
Nicholl DDM; Hanly PJ; Zalucky AA; Mann MC; MacRae JM; Poulin MJ; Handley GB; Sola DY; Ahmed SB
J Clin Sleep Med; 2018 Sep; 14(9):1509-1520. PubMed ID: 30176965
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal hypoxemia severity influences the effect of CPAP therapy on renal renin-angiotensin-aldosterone system activity in humans with obstructive sleep apnea.
Nicholl DDM; Hanly PJ; Zalucky AA; Handley GB; Sola DY; Ahmed SB
Sleep; 2021 May; 44(5):. PubMed ID: 33734385
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.
Calhoun DA; Nishizaka MK; Zaman MA; Harding SM
Chest; 2004 Jan; 125(1):112-7. PubMed ID: 14718429
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea.
Nicholl DD; Hanly PJ; Poulin MJ; Handley GB; Hemmelgarn BR; Sola DY; Ahmed SB
Am J Respir Crit Care Med; 2014 Sep; 190(5):572-80. PubMed ID: 25033250
[TBL] [Abstract][Full Text] [Related]
13. Evening and morning blood gases in patients with obstructive sleep apnea.
Guardiola J; Yu J; Hasan N; Fletcher EC
Sleep Med; 2004 Sep; 5(5):489-93. PubMed ID: 15341895
[TBL] [Abstract][Full Text] [Related]
14. Diurnal changes and levels of fibrin generation are not altered by continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA). A randomised, placebo-controlled crossover study.
McEwen BJ; Phillips CL; Morel-Kopp MC; Yee BJ; Sullivan DR; Ward CM; Tofler GH; Grunstein RR
Thromb Haemost; 2012 Oct; 108(4):701-9. PubMed ID: 22918526
[TBL] [Abstract][Full Text] [Related]
15. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease.
Gjørup PH; Sadauskiene L; Wessels J; Nyvad O; Strunge B; Pedersen EB
Am J Hypertens; 2007 Jan; 20(1):44-52. PubMed ID: 17198911
[TBL] [Abstract][Full Text] [Related]
16. Effects of continuous positive airway pressure therapy on plasma aldosterone levels in patients with obstructive sleep apnea: A meta-analysis.
Deng G; Qiu ZD; Li DY; Fang Y; Zhang SM
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):619-625. PubMed ID: 27752893
[TBL] [Abstract][Full Text] [Related]
17. Serum amyloid a in obstructive sleep apnea.
Svatikova A; Wolk R; Shamsuzzaman AS; Kara T; Olson EJ; Somers VK
Circulation; 2003 Sep; 108(12):1451-4. PubMed ID: 12952844
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled study of CPAP effect on plasma aldosterone concentration in patients with resistant hypertension and obstructive sleep apnea.
Lloberes P; Sampol G; Espinel E; Segarra A; Ramon MA; Romero O; Ferrer R; Martínez-Garcia MA; Tovar JL
J Hypertens; 2014 Aug; 32(8):1650-7; discussion 1657. PubMed ID: 24879492
[TBL] [Abstract][Full Text] [Related]
19. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension.
Gonzaga CC; Gaddam KK; Ahmed MI; Pimenta E; Thomas SJ; Harding SM; Oparil S; Cofield SS; Calhoun DA
J Clin Sleep Med; 2010 Aug; 6(4):363-8. PubMed ID: 20726285
[TBL] [Abstract][Full Text] [Related]
20. The Role of Aldosterone in OSA and OSA-Related Hypertension.
Wang Y; Li CX; Lin YN; Zhang LY; Li SQ; Zhang L; Yan YR; Lu FY; Li N; Li QY
Front Endocrinol (Lausanne); 2021; 12():801689. PubMed ID: 35095768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]